HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts
Lenacapivir, an innovative injectable HIV prevention drug requiring only two injections annually, shows significant promise in reducing global HIV cases and is 99% effective when used consistently. However, experts at the AIDS 2026 Conference warn that cuts to US foreign aid will prevent vulnerable populations from accessing this breakthrough medication. The decline in global HIV prevention investment threatens to undermine the potential impact of this new preventive technology.
1 Article
Trace's outlet lean is shown first — tap Left / Center / Right on each source to add your rating too.
- The GuardianTrace: Left
HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts
Lenacapivir, an innovative injectable HIV prevention drug requiring only two injections annually, shows significant promise in reducing global HIV cases and is 99% effective when used consistently. However, experts at the AIDS 2026 Conference warn that cuts to US foreign aid will prevent vulnerable populations from accessing this breakthrough medication. The decline in global HIV prevention investment threatens to undermine the potential impact of this new preventive technology.
Rate outletRead original